Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 42,037 | 38,338 | 37,011 | 34,838 | 26,852 |
| Cost of Goods | 10,182 | 9,520 | 8,859 | 7,686 | 5,944 |
| Gross Profit | 31,855 | 28,818 | 28,152 | 27,152 | 20,908 |
| Operating Expenses | 63,559 | 52,170 | 50,547 | 31,809 | 46,368 |
| Operating Income | -31,522 | -22,832 | -21,536 | -3,971 | -24,516 |
| Interest Expense | 4 | 4 | 6 | 4 | 3 |
| Other Income | 2,336 | 2,275 | 1,293 | 370 | 30 |
| Pre-tax Income | -29,190 | -20,561 | -20,249 | -3,605 | -24,489 |
| Income Tax | 14 | 57 | N/A | -1,957 | 134 |
| Net Income Continuous | -29,204 | -20,618 | -20,249 | -1,648 | -24,623 |
| Net Income | $-29,204 | $-20,618 | $-20,249 | $-1,648 | $-24,623 |
| EPS Basic Total Ops | -1.10 | -0.78 | -0.77 | -0.06 | -0.97 |
| EPS Basic Continuous Ops | -1.10 | -0.78 | -0.77 | -0.06 | -0.97 |
| EPS Diluted Total Ops | -1.10 | -0.78 | -0.77 | -0.06 | -0.97 |
| EPS Diluted Continuous Ops | -1.10 | -0.78 | -0.77 | -0.06 | -0.97 |
| EBITDA(a) | $-29,859 | $-21,175 | $-18,797 | $-1,343 | $-22,365 |